Feature | April 10, 2014

Ten-Year-Old Boy is Florida’s First Pediatric Patient to Receive S-ICD

April 10, 2014 — Cardiologists at Arnold Palmer Hospital for Children performed Florida’s first pediatric implant of a new device to prevent sudden cardiac arrest.

The device, called a subcutaneous defibrillator, protects patients from sudden cardiac arrest by providing an electrical impulse to muscles surrounding the heart. It is the world’s first device to provide protection from sudden cardiac arrest while not touching the heart or blood vessels.

Sudden cardiac arrest is a condition in which the heart suddenly and unexpectedly stops beating. If this happens, blood stops flowing to the brain and other vital organs. The condition usually causes death if not treated within minutes. [1]

Cardiologists at the hospital implanted the subcutaneous defibrillator into Jose Ramos, a 10-year-old Kissimmee, Fla., boy who went into sudden cardiac arrest in February 2014 and received cardiopulmonary resuscitation from his father to save his life.

“With the subcutaneous defibrillator, we now have a way to prevent sudden cardiac arrest in pediatric patients without having wires running through their veins and into the heart,” says Rodrigo Nehgme, electrophysiologist and cardiologist at Arnold Palmer Hospital. “It is a less invasive solution with fewer risks and will save the lives of young patients at risk for sudden cardiac arrest.”

The subcutaneous defibrillator is about the size of a deck of cards and is implanted just beneath the skin below the armpit. Cardiologists then run a wire, also beneath the skin, from the device to the front of the chest and up toward the neck. Whereas older technology monitored individual heartbeats, this new device actually analyzes heart rhythm and provides an electrical impulse when the heart goes into a dangerous rhythm.

Approximately 2,000 of the subcutaneous defibrillators have been implanted in the United States, with Ramos being only the fifth pediatric case.

References:

1. National Heart, Lung and Blood Institute (https://www.nhlbi.nih.gov/health/health-topics/topics/scda/)

For more information: www.arnoldpalmerhospital.com

 

Related Content

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab| September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Overlay Init